Thyroid DiseasesNCT04569513
The Analysis of Thyroidectomy and Parathyroidectomy
An observational study of Thyroid Diseases and Parathyroid Diseases, run by National Taiwan University Hospital at 1 site in Taiwan.
Trial summary
To analyze surgery or not, different surgical methods, timing of surgery, and alternative managements for patients of thyroid or parathyroid disease. Read more about this study
- Who is it for?
- Ages 20 years and older
- Conditions the study is for
- Thyroid Diseases, Parathyroid Diseases
- What is being tested?
- Thyroid and parathyroid disease
- How many people
- 12,000 participants
- Where
- 1 siteTaiwan
- Study dates
- 10 Jun 2021to 31 Dec 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients of thyroid or parathyroid disorder at National Taiwan University Hospital (NTUH).
Who may be able to join
- age more than 20 years
- thyroid or parathyroid disorder
- willing to receive management at National Taiwan University Hospital (NTUH)
Who cannot join
- age less than 20 years
Trial locations and contacts
1 site in 1 country.
Taiwan1 site, 1 recruiting
- Recruiting
Ting-Chun Kuo
Taipei, 103
Ting-Chun Kuo, MD, +886972653245, tinakuo1204@gmail.com
About this study
To analyze surgery or not, different surgical methods, timing of surgery, and alternative managements for patients of thyroid or parathyroid disease.
Read the detailed description
Utilizing our institutional database, tissue bank, and electronic medical charts to surgery or not, different surgical methods, timing of surgery, and alternative managements for patients of thyroid or parathyroid disease.
- Conditions
- Thyroid Diseases, Parathyroid Diseases
- Being tested
- Thyroid and parathyroid disease
- Keywords
- surgery, ablation, minimal invasive surgery
- Medical subject headings
- Thyroid Diseases, Parathyroid Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Thyroid and parathyroid diseaseBiological
To analyze surgery or not, different surgical methods, timing of surgery, and alternative managements for patients of thyroid or parathyroid disease.
What is being measured
The primary outcome is the main question the study is designed to answer.
Survival
Death or live
Measured: 1 month
Progression
Recurrence or metastasis
Measured: 1 month
Secondary outcomes (2)
Tumor growth
Size variation of tumor
Measured: 1 cm/month
Life quality
Cosmetic and symptoms, using short-form (SF)-36 and patient satisfaction scale (as tumor volume reduction rate, satisfy as >50%)
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Sep 2020
- Study start10 Jun 2021 (estimated)
- Primary completion30 Jun 2024 (estimated)
- Study completion31 Dec 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Thyroid DiseasesStudies of the same condition, open and under way.
- More trials run by National Taiwan University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 12,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- National Taiwan University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Ming-Hsun Wu, MDPhD, Principal investigator, Department of Surgery, National Taiwan University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04569513
- Sponsor's protocol ID
- 201906051RINA
- Status last verified
- Jun 2021
- First submitted
- 11 May 2020
- Last updated
- 9 Jun 2021
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Jun 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Analysis of Thyroidectomy and Parathyroidectomy
- ClinicalTrials.gov ID
- NCT04569513
- Acronym / sponsor ID
- 201906051RINA
- Conditions
- Thyroid Diseases, Parathyroid Diseases
- Keywords
- surgery, ablation, minimal invasive surgery
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 12,000 participants (estimated)
- Lead sponsor
- National Taiwan University HospitalUniversity, hospital or other
- Study start
- 10 Jun 2021 (estimated)
- Primary completion
- 30 Jun 2024 (estimated)
- Study completion
- 31 Dec 2024 (estimated)
- First posted
- 30 Sep 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To analyze surgery or not, different surgical methods, timing of surgery, and alternative managements for patients of thyroid or parathyroid disease.
Detailed description
Utilizing our institutional database, tissue bank, and electronic medical charts to surgery or not, different surgical methods, timing of surgery, and alternative managements for patients of thyroid or parathyroid disease.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 20 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients of thyroid or parathyroid disorder at National Taiwan University Hospital (NTUH).
Key inclusion criteria (3 listed)
- age more than 20 years
- thyroid or parathyroid disorder
- willing to receive management at National Taiwan University Hospital (NTUH)
Key exclusion criteria (1 listed)
- age less than 20 years
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Thyroid and parathyroid diseaseTo analyze surgery or not, different surgical methods, timing of surgery, and alternative managements for patients of thyroid or parathyroid disease. | Biological | – |
Primary outcome
Survival
Time frame: 1 month
Death or live
Progression
Time frame: 1 month
Recurrence or metastasis
2 secondary outcomes
Tumor growth
Time frame: 1 cm/month
Life quality
Time frame: 1 year
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Jun 2021.
Related trials for Thyroid Diseases
Enrolling by invitationObservational study
Head and Neck Cancer Strategies
Head and Neck Cancer (H&N), Thyroid Cancer
Not yet recruitingObservational study
Serum Treg/Th17-Related Cytokines and Systemic Inflammatory Indices in Differentiated Thyroid Cancer
Differentiated Thyroid Cancer (DTC), Papillary Thyroid Carcinoma
Not yet recruitingPhase 1/2
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
Thyroid Cancer
Recruiting
Radiofrequency Ablation Study in LatinX Patients
Thyroid Nodule
Active, not recruitingPhase 4
Hydroxychloroquine in Mild Graves' Orbitopathy
Graves Ophthalmopathy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ming-Hsun Wu, MDPhD principal investigator
Department of Surgery, National Taiwan University Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Thyroid Diseases and Parathyroid Diseases, run by National Taiwan University Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 9 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Ting-Chun Kuo (+886223123456 ext. 62557, tinakuo1204@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Survival (time frame: 1 month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2021.